Liquid Biopsy Market Global Insights, Growth By 2024-2032 | IMARC Group
The latest report by IMARC Group, titled “ Liquid Biopsy Market Report by Product And Service (Kits and Reagents, Platforms and Instruments, Services), Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA, and Others), Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Others), End User (Hospitals and Laboratories, Academic and Research Centers, and Others), and Region 2024-2032 ”, offers a comprehensive analysis of the industry, which comprises insights on the market. Liquid Biopsy Market Outlook: The global liquid biopsy market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.5% during 2024-2032. Competitive Landscape: The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market. ANGLE plc Biocept Inc. Bio-Rad Laborat...